
Pharmaceutical Executive Daily: FDA Grants Ultomiris Accelerated Approval in the U.S.
22/10/2026
0:00
2:53
FDA grants Ultomiris accelerated approval for primary immunoglobulin A nephropathy, a pharma funding roundup covers Alcon’s $550 million acquisition of Neurotech and AI Proteins’ collaboration with Astellas, and Incubate’s John Stanford on which therapeutic areas MFN deals might hit hardest.
Altri episodi di "Pharmaceutical Executive"



Non perdere nemmeno un episodio di “Pharmaceutical Executive”. Iscriviti all'app gratuita GetPodcast.








